# In-situ Cytokines Expression in the CNS in Amyotrophic Lateral Sclerosis (ALS)

> **NCT02582385** · — · COMPLETED · sponsor: **Brugmann University Hospital** · enrollment: 5 (actual)

## Conditions studied

- Amyotrophic Lateral Sclerosis

## Interventions

- **OTHER:** in-situ cytokine expression

## Key facts

- **NCT ID:** NCT02582385
- **Lead sponsor:** Brugmann University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2015-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02582385

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02582385, "In-situ Cytokines Expression in the CNS in Amyotrophic Lateral Sclerosis (ALS)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02582385. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*